awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30978102-205C6070-8D50-443A-9FFB-0DF558A3623E
Q30978102-205C6070-8D50-443A-9FFB-0DF558A3623E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30978102-205C6070-8D50-443A-9FFB-0DF558A3623E
Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data.
P2860
Q30978102-205C6070-8D50-443A-9FFB-0DF558A3623E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30978102-205C6070-8D50-443A-9FFB-0DF558A3623E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7b1acb0afafa2ec9ce6e2e01c747ed0c8ae365a6
P2860
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.